Vaccine stocks gained in premarket trading, Moderna shares rose more than 7% and BioNTech rose 5%

Tiger Newspress2021-11-26

Vaccine stocks gained in premarket trading, Moderna shares rose more than 7% and BioNTech rose 5%.

A new variant of the coronavirus that causes Covid-19 -- called B.1.1.529 -- has been identified in South Africa, with officials there saying it’s of concern. Fears a new strain could fuel outbreaks in many countries, straining health systems, potentially evading vaccines and complicating efforts to reopen economies and borders, sent a wave of risk aversion across global markets Friday.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

  • JeremyKok
    2021-11-27
    JeremyKok
    Pharmaceutical companies that manufactures covid-19 vaccines and treatment will gain. If current vaccine is ineffective against the new variant, the first pharmaceutical company that can produce a vaccine for the new variant with high efficacy will profit the most. Best to buy pharmaceutical ETF during the dip and hold. Do your own due diligence before you invest.
  • TrillionDM
    2021-11-27
    TrillionDM
    Follow
  • Abgi
    2021-11-26
    Abgi
    Ok
  • FannyNg
    2021-11-26
    FannyNg
    Here we go again, stay calm if holding good stocks 
  • Mireyachen
    2021-11-26
    Mireyachen
    Tonight see red sea
    • Foxie
      Black friday sales.
  • PP_July
    2021-11-26
    PP_July
    Valuable info☺️
发表看法
18